Revenue ($USD) : $2,566,500,000
R&D spend : $93,800,000
Employees : 12,700
Fiscal year end : 12/31/2023
CEO : Paul Keel

www.envistaco.com

Envista has a global family of more than 30 dental brands, including Nobel Biocare, Ormco, Dexis and Kerr. The company provides a comprehensive range of dental solutions, including dental implants, orthodontics and digital imaging technologies, catering to a wide spectrum of clinical needs. Envista’s products and technologies support the diagnosis, treatment and prevention of dental conditions, as well as enhancing the aesthetics of the human smile. –CN